Science
Mechanism of Action
This tetrapeptide operates by signaling dermal fibroblasts to significantly increase their production of crucial extracellular matrix molecules, including collagen 1, collagen 4, hyaluronic acid, and fibronectin. This augmented synthesis directly contributes to enhanced skin architecture, promoting improved mechanical properties, increased density, and greater volume. Furthermore, the broader class of tetrapeptides often exhibits ancillary anti-inflammatory and antioxidant activities, with some capable of influencing neurotransmitter function to minimize expression lines.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
While TETRAPEPTIDE-39's precise solubility is not specified, it is indicated that peptides within this patented group are solubilizable. To optimize general peptide stability and minimize deamidation, formulations typically benefit from a pH range between 3 and 5.
Safety
Safety Profile
Specific safety assessments from regulatory bodies such as CIR, SCCS, or FDA for TETRAPEPTIDE-39 are not currently available. However, tetrapeptides as a class are generally regarded as 'physiologically acceptable' for topical and transdermal cosmetic applications.
Your Skin
Skin Compatibility
Our Assessment
Verdict
TETRAPEPTIDE-39 demonstrates a compelling mechanism for enhancing skin structure and mitigating signs of aging, yet further specific clinical efficacy and comprehensive safety data are required for a definitive assessment.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources